Randomized Study of Decitabine in Maintenance Therapy of Acute Myeloid Leukemia (AML)
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical study is to find out whether continued therapy with decitabine
after achieving a remission in acute myeloid leukemia (AML) patients can help prolong the
remission and prevent relapse of the disease.